RecruitingNCT05505500
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
Studying Glomerular disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Michigan
- Principal Investigator
- Eloise Salmon, M.D.University of Michigan
- Intervention
- Interview(behavioral)
- Enrollment
- 150 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2022 – 2026
Study locations (1)
- University of Michigan, Ann Arbor, Michigan, United States
Collaborators
Northwestern University · Food and Drug Administration (FDA)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05505500 on ClinicalTrials.govOther trials for Glomerular disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06858319Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.Novartis Pharmaceuticals
- RECRUITINGPHASE4NCT05839314Effect of Huaier Granule on the Treatment of Idiopathic Membranous NephropathyChinese PLA General Hospital
- RECRUITINGNCT04528446The Impact of Glomerular Disorders on Bone Quality and StrengthColumbia University
- RECRUITINGNCT03929887KOrea Renal Biobank NEtwoRk System TOward NExt-generation AnalysisSeoul National University Hospital
- RECRUITINGNCT02954419IgA Nephropathy Biomarkers Evaluation Study (INTEREST)Sun Yat-sen University
- RECRUITINGPHASE2NCT00977977Rituximab Plus Cyclosporine in Idiopathic Membranous NephropathyNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)